Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Bridge Investment Group Holdings Inc. Reports Fourth Quarter and Full Year 2024 Results
-
Vicero’s Novel Cancer Immunotherapy Demonstrates Dual-Target Precision with Improved Safety Profile
-
StorONE Disrupts Market - Saving 75% in AI or Cold Data Storage Compared to Flash
-
Industry Veteran and VC Investor Strengthen the BTB Therapeutics Board
-
Tennessee Flight Training Receives Award for Excellence
-
MITSUBISHI MOTORS ANNOUNCES PRICING AND PACKAGING FOR REFRESHED 2025 OUTLANDER
-
Fifth Third Private Bank's New Delaware Trust Administrative Office Highlights Wealth Planning Expertise, Meets Complex Client Needs
-
Westlake Royal Building Products™ Expands Award-Winning Grove Collection™ Trim Line
-
Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm's Innovative T Cell Therapies for Solid Cancers
-
Windstream Wholesale Expands Network Connectivity in Myrtle Beach
-
Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio
-
Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025
-
Rocket Lab Clears Critical Design Review for Space Force VICTUS HAZE Mission
-
SaverOne Granted New Patent in the United States Further Expanding its IP Portfolio
-
Tokyo Lifestyle Co., Ltd. Announces the Opening of a New Reiwatakiya Franchise Store in Bangkok, Thailand
-
Aureus Greenway Holdings Inc. to Ring the Nasdaq Closing Bell on Tuesday, February 25
-
Brera Holdings PLC Executives to Attend Financial Times Business of Football Summit 2025
-
Singular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBT
-
Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital
-
Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy
-
Real American Beer Takes Over New York
-
Recursion to Report Fourth Quarter and Fiscal Year 2024 Business Updates and Financial Results on February 28th
-
Inhibikase Announces Expansion of Senior Leadership Team
-
Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company
-
Rezolve Ai Launches Groundbreaking $1 Billion Bitcoin Treasury to Fuel the Future of AI-Powered Crypto Commerce
-
Clip Money Inc. Announces US$2,000,000 Convertible Note Financing
-
MediWound to Present at the 45th Annual TD Cowen Health Care Conference
-
Lincoln Educational Services Reports Strong Results for Fourth Quarter and Full Year 2024; Provides Outlook for Continued Strong Growth in 2025
-
Bradford Health Services Reaffirms Commitment to Veterans, Clarifies Position on Eastern Alabama Healthcare Center
-
Arcutis Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE® (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with Mild to Moderate Atopic Dermatitis in Pediatric
-
Gabelli Funds to Host Pump, Valve & Water Systems Symposium at the Harvard Club, New York City
-
Constellium Joins Industry Consortium for Lightweight Vehicle Chassis Innovation Project
-
LENZ Therapeutics to Participate in Upcoming Investor Conferences
-
PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
-
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
-
Bastion Insights Empowers Organizations with Research Bootcamps
-
KnowBe4 Secures Leadership Position in Frost Radar™: Human Risk Management, 2024 Report
-
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
ASML reports transactions under its current share buyback program
-
Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET
-
Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients
-
Study: Brain Exercise Lowers Fatigue Symptoms in Multiple Sclerosis
-
TFS HealthScience Announces Leadership Transition: Katarina Ageborg Appointed Chairman of the Board, Markus Granlund Named Acting CEO
-
Global Immigration Partners Announces New Office in Malta to Deliver Premier Immigration Solutions
-
Kaldvik AS (KLDVK): Q4 2024 Webcast results 26 February 2025 at 11:00 (CET)
-
-
Red Tree Builders-Alair Asheville's "Green Haven" Wins Green Builder Media's 2025 Green Home of the Year Award for General Excellence
-
RONN Inc. JV Partner HES Secures Mega-Project Agreement in South Korea
-
New Rise Begins Commercial SAF Production and Secures First Order
